Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Yelling that the future and their lives depend on ending fossil fuels, tens of thousands of protesters on Sunday kicked off a week where leaders will try once again to curb climate change primarily caused by coal, oil and natural gas.
Atlantic storm Lee — which made landfall at near-hurricane strength, bringing destructive winds and torrential rains to New England and Maritime Canada — kept weakening Sunday after officials withdrew warnings and predicted the storm would disappear early this week.
NASA said Thursday that the study of UFOs will require new scientific techniques, including advanced satellites as well as a shift in how unidentified flying objects are perceived.
An effort to destigmatize the use of overdose reversal drugs that started as a pilot in two West Virginia counties has expanded to all thirteen states in Appalachia this year.
States and Native American tribes will have greater authority to block energy projects such as natural gas pipelines that could pollute rivers and streams under a final rule issued Thursday by the Biden administration.
